Acuren Corp
NYSE:TIC
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Acuren Corp
Acuren Corp. engages in providing nondestructive testing, inspection, engineering and lab testing services. The company is headquartered in Tomball, Texas. The company went IPO on 2023-10-12. The firm provide these essential and often compliance-mandated (often at customer locations) services in the industrial space and are focused on the recuring maintenance needs of its customers. The firm operates in the service category referred to as Testing, Inspection and Certification (TIC). These activities include Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid costly accidents and comply with regulatory requirements without destroying the asset or component. The company operates from approximately 119 service centers and over 22 engineering and lab facilities. The company operates in the United States and Canada, and has limited operations located in the United Kingdom.
Acuren Corp. engages in providing nondestructive testing, inspection, engineering and lab testing services. The company is headquartered in Tomball, Texas. The company went IPO on 2023-10-12. The firm provide these essential and often compliance-mandated (often at customer locations) services in the industrial space and are focused on the recuring maintenance needs of its customers. The firm operates in the service category referred to as Testing, Inspection and Certification (TIC). These activities include Nondestructive Testing (NDT) techniques such as radiography, ultrasonic testing, magnetic particle inspection, penetrant testing, and visual inspection. NDT activities include inspection and evaluation of industrial equipment through various technology-enabled methods to ensure asset integrity, avoid costly accidents and comply with regulatory requirements without destroying the asset or component. The company operates from approximately 119 service centers and over 22 engineering and lab facilities. The company operates in the United States and Canada, and has limited operations located in the United Kingdom.
Revenue Growth: TIC Solutions reported Q3 revenue of $473.9 million, reflecting substantial year-over-year growth due to the NV5 acquisition. Combined year-to-date revenue grew approximately 4.7%.
Guidance Reaffirmed: Management reaffirmed full-year 2025 revenue guidance of $1.530 billion to $1.565 billion and adjusted EBITDA of $240 million to $250 million, with 2026 revenue expected to grow 3–5%.
Synergy Target Raised: The cost synergy target from the NV5 acquisition was increased from $20 million to $25 million, expected to be fully realized by mid-2027.
Strong Data Center Momentum: Data center revenue more than doubled year-to-date but remains a small (~3%) part of the mix, with significant growth ambition and cross-segment expansion.
Segment Performance: Consulting Engineering saw double-digit growth, Geospatial performed well with mid-single-digit gains, while Inspection and Mitigation faced project timing and chemical sector softness.
Capital Strengthened: A $250 million equity raise in October bolstered the balance sheet, with focus on deleveraging and ongoing M&A.
Integration on Track: Integration of Acuren and NV5 is progressing, with early cross-selling and operating model alignment supporting long-term growth.